Current status of adjuvant chemo- and hormone therapy in resectable breast carcinoma
Senn, H.J.
Schweizerische Rundschau für Medizin Praxis 76(43): 1193-1199
1987
ISSN/ISBN: 1013-2058 PMID: 3313623 Document Number: 302611
Document emailed within 1 workday
Related Documents
Yamaguchi, M.; Fukuyama, Y.; Ichinose, Y. 2003: Current status of the neo-adjuvant and adjuvant therapy for the resectable non-small cell lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 30(2): 203-208Abe, R.; Tsuchiya, A.; Koie, H.; Ono, K.; Abo, S.; Saito, K.; Tsukamoto, M.; Sato, T.; Mori, S.; Motoki, R. 1988: Cooperative research on post-operative adjuvant therapy of breast cancer. Tohoku Society of Adjuvant Chemo-endocrine Therapy of Breast Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 15(9): 2707-2712
Schneider, G. 1993: Adjuvant hormone therapy in breast carcinoma Deutsche Medizinische Wochenschrift 118(25): 961-962
Osaki, A.; Saeki, T. 2011: Current status and future direction of postoperative adjuvant therapy in breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 38(9): 1406-1411
Wolff, A.C. 2005: Current status of taxanes as adjuvant therapy for early-stage breast cancer International Journal of Fertility and Women's Medicine 50(5 Pt 1): 227-229
Taguchi, T. 1998: Adjuvant for breast cancer chemo-endocrine therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 25(4): 453-467
Ikeda, T. 1994: "State of the art" of adjuvant chemo-endocrine therapy for breast cancer in Japan Gan to Kagaku Ryoho. Cancer and ChemoTherapy 21(Suppl 3): 370-376
Kitamura, M.; Tominaga, T.; Hayashi, K.; Takahashi, I.; Kosaki, G. 1985: Preliminary report of adjuvant chemo-endocrine therapy for breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 12(1): 111-117
Antoniou, E.A.; Margonis, G.A.; Amini, N.; Anastasiou, M.; Angelou, A.; Kim, Y.; Kouraklis, G. 2016: Sorafenib as an adjuvant therapy for resectable hepatocellular carcinoma: a single center experience Journal of Buon: Official Journal of the Balkan Union of Oncology 21(5): 1189-1194
Goldhirsch, A.; Neuenschwander, H.; Castiglione, M.; Senn, H.J.; Cavalli, F. 1990: Adjuvant systemic therapy in breast carcinoma in the 1990s: status of things and open questions Schweizerische Medizinische Wochenschrift 120(47): 1771-1783
Hudis, C.A.; Seidman, A.D.; Baselga, J.; Raptis, G.; Lebwohl, D.; Gilewski, T.; Currie, V.; Moynahan, M.E.; Sklarin, N.; Fennelly, D. 1995: Sequential adjuvant therapy with doxorubicin/paclitaxel/cyclophosphamide for resectable breast cancer involving four or more axillary nodes Seminars in Oncology 22(6 Suppl 15: 18-23
Neoptolemos, J.P.; Baker, P.; Beger, H.; Link, K.; Pederzoli, P.; Bassi, C.; Dervenis, C.; Friess, H.; Büchler, M. 1997: Progress report. A randomized multicenter European study comparing adjuvant radiotherapy, 6-mo chemotherapy, and combination therapy vs no-adjuvant treatment in resectable pancreatic cancer (ESPAC-1) International Journal of Pancreatology: Official Journal of the International Association of Pancreatology 21(2): 97-104
O'Connell, M.J. 2004: Current status of adjuvant therapy for colorectal cancer Oncology 18(6): 751
Boccardo, F.; Valenti, G.; De Menech, R.; Zanardi, S. 1986: Adjuvant hormone therapy of breast neoplasms. A critical review of the literature and perspectives Minerva Ginecologica 38(7-8): 659-665
Kato, A.; Miyazaki, M. 2014: Current status of adjuvant therapy for biliary tract cancer Nihon Geka Gakkai Zasshi 115(4): 206-211
Semiglazov, V.F.; Moiseenko, V.M.; Ivanova, O.A. 1986: Prospective randomized study of the efficacy of adjuvant hormone therapy in patients with breast cancer Voprosy Onkologii 32(8): 31-34
Uhlenbruck, G.; VAN Leendert, R.; Schneider, B.; Beuth, J. 2010: Reduced side-effects of adjuvant hormone therapy in breast cancer patients by complementary medicine In Vivo 24(5): 799-802
Hudis, C.A. 1999: The current state of adjuvant therapy for breast cancer: focus on paclitaxel Seminars in Oncology 26(1 Suppl 2: 1-5
Cleton, F.J.; Engelsman, E.; Nooy, M. 1986: Adjuvant therapy in patients with operable breast carcinoma Nederlands Tijdschrift Voor Geneeskunde 130(16): 719-721
Kuhl, H. 1997: Current status: hormone substitution and risk of endometrial carcinoma Zentralblatt für Gynakologie 119(6): 296-297